Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Sep 27;4(3):109-114.
doi: 10.2478/rir-2023-0018. eCollection 2023 Sep.

Lupus clinical trials and the promise of future therapies

Leila Khalili  1 , Wei Tang  1 , Anca D Askanase  1
Affiliations
Editorial

Lupus clinical trials and the promise of future therapies

Leila Khalili et al. Rheumatol Immunol Res. .
No abstract available

PubMed Disclaimer

References

    1. Highlights of Prescribing Information Voclosporin Accessed 08/31/2023. US Food and Drug Administration. 2021 https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213716s000lbl.pdf
    1. Highlights of Prescribing Information Anifrolumab Accessed 08/31/2023. US Food and Drug Administration. 2022 https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761123s000lbl.pdf
    1. Highlights of Prescribing Information Belimumab Accessed 08/31/2023. US Food and Drug Administration. 2023 https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125370s079,761...
    1. Morand EF, Furie R, Tanaka Y. Trial of Anifrolumab in Active Systemic Lupus Erythematosus. N Engl J Med. 2020;382:211221. et al. - PubMed
    1. Rovin BH, Teng YKO, Ginzler EM. Eficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial [published correction appears in Lancet. 2021 May 29;397(10289):2048]. Lancet. 2021. 397:2070–2080. et al. - PubMed

Publication types

LinkOut - more resources